Complement‑targeted therapeutics continue to expand, with C3, C5, and alternative‑pathway inhibitors advancing through clinical pipelines. Creative Biolabs’ complement assay kit suite spans the ...

Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES ...

(MENAFN- EIN Presswire) EINPresswire/ -- Creative Biolabs has expanded its portfolio of primary cell systems and functional assay tools, expanding its selection of primary macrophage preparations, ...